Supply Chain
Variation is a scary concept for providers, whether you're talking about healthcare costs or outcomes of care delivery. It's inevitable, and part of the day-to-day routine for any hospital. But variation can put patients at risk, incur penalties and negatively impact a provider's reputation.
The ideal prescription for hospitals wanting to reduce their pharmaceutical costs could be tighter controls and staying on top of shortages.
The delivery of coronary artery stents is a procedure that affects over 1 million patients each year in the United States. With an aging population, the declining cost of stents and reimbursement tracking with the consumer price index (2-4 percent margins), the market for stenting continues to grow.
More than 80 percent of hospitals in the U.S. expect to be engaging in sustainability purchasing within two years, according to a recent survey. For the hospitals that expect to jump on the green bandwagon, there's a lot to learn.
The most successful hospital supply chain leaders are changing the usual conversations with clinical and administrative leaders into more meaningful collaboration by offering new, actionable insights through the use of business analytics.
The Centers for Medicare & Medicaid Services recent 10-year projection of national health expenditures includes retail spending on prescription drugs, but a more complete picture of pharma spending would include the nonretail segment.
In its semiannual Economic Outlook survey, Premier, Inc., asked hospital supply chain, materials management and C-suite executives to reveal the trends impacting their supply chains over the next year. Here are the top five issues.
Every interventional cardiac cath procedure requires the use of an associated monitoring system. Negotiation of this technology requires a deep understanding of how these systems can be highly configurable, how components can be priced and discounted differently.
Savvy healthcare supply chain leaders must go beyond medical product pricing to achieve the next level of savings for their organizations. Here are 3 areas to consider if you are searching for additional savings.
Are hospitals exploiting the 340B drug discount program? Critics of the federal government's program have some new evidence in the debate over healthcare subsidies.